New immunotherapeutic strategy to treat T-cell acute lymphoblastic leukemia

by IrsiCaixa

The study uses genetically modified immune cells that specifically target the CD1a molecule of the tumour cells, suggesting a new treatment with less adverse effects for patients

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

More than 6% of Europeans suffer from de...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

A study in 27 European countries led by researchers from King’s Coll...

Photos Stream